Good Day BIO Newsletter

What a day on Capitol Hill. Yesterday brought the introduction of a bill that would fix the small molecule “pill penalty” in the Inflation Reduction Act, the passage of legislation to restore immediate R&D expensing, and a discussion on the need for PBM reform—we recap everything below. (766 words, 3 minutes, 49 seconds)

The House readies for a possible vote on restoring immediate R&D expensing, and BIO’s Phyllis Arthur says the next health crisis—antimicrobial resistance—is already here. (576 words, 2 minutes, 52 seconds)

We could eliminate cervical cancer—with widespread HPV vaccination. We have details on a promising new study, plus a panel discussion last week at UCLA about the growing problem of antimicrobial resistance. (646 words, 3 minutes, 13 seconds)

Beginning a new week with a look at BIO’s congressional priorities for 2024—and how you can take action on some of them—as well as progress on Biden’s bioeconomy executive order. (544 words, 2 minutes, 43 seconds)

Ending the week with bipartisan Senators calling for IP protections on the global stage, and a look at the world’s first facility (from BIO member LanzaJet) to produce SAF from ethanol. (438 words, 2 minutes, 11 seconds)

BIO’s report on the vaccine pipeline—just released today—explores the need for more investment and more research into novel pathogens. Meanwhile, USDA has proposed regulatory changes to genetically engineered crops, but BIO explains why they’re too complicated. (514 words, 2 minutes, 34 seconds)

Witnesses told a Senate Judiciary hearing yesterday that predictable patent protection keeps U.S. an innovation leader—plus, a new study shows how updated COVID vaccines protect against thrombosis. (549 words, 2 minutes, 44 seconds)

A federal commission explains why biotech is a national security issue—plus, a recap of last week’s Davos and what BIO members said at the event. (575 words, 2 minutes, 52 seconds)

Legislation restoring R&D tax deductions advanced in the House Ways & Means Committee – it's a good time to join the BIOAction campaign and ask your lawmaker to support it. Plus, BIO's CEO Rachel King says government meddling could end a golden age of new drugs, and a UCLA event today looks at the threat of AMR. (643 words, 3 minutes, 12 seconds)

COVID-19, flu, and RSV are here—but for the first winter ever, we have vaccines for all three. Meanwhile, USDA has awarded $19 million in grants to boost biofuels. (417 words, 2 minutes, 5 seconds)